| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |